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Past
events
Last year the Nuclear Medicine Department of the Military 
Institute of Medicine (MIM) in Warsaw, Poland was awarded the 
European Union of Medical Specialist/European Board of Nuclear 
Medicine (UEMS/EBNM) Accreditation. The diploma was pre-
sented to the Head of the Department, Professor Eugeniusz Dziuk 
MD PhD, during a special session that was held in Vienna during 
the Annual Congress of the European Association of Nuclear 
Medicine (9–13 Oct 2010).
The abovementioned department is the first in Poland to 
receive this European accreditation. Until now there have only 
been 30 Nuclear Medicine Departments and 45 Nuclear Medicine 
Training Centres which have fulfilled the strict criteria to receive 
UEMS/EBNM Accreditation.
The Nuclear Medicine Department MIM was founded in 1963. 
Since 1983 it has been headed by Prof. Eugeniusz Dziuk.
The Department of Nuclear Medicine is a diagnostic facility of 
the Central Teaching Hospital Ministry of Defence, Military Institute of 
Medicine in Warsaw and has the Certificate of Quality Management 
System ISO PN-EN ISO 9001:2001 and AQAP 2120:2003 certificate 
of the National Institution in NATO. It has been awarded the valida-
tion of the Mayo Cardiac Phantom, confirming that the system in the 
Nuclear Medicine Department MIM is acceptable for the multi-centre 
trial SPECT study and Pearl of Medicine Award certificate in Poland.
The Department consists of a Scintigraphy Laboratory and 
a Radioimmunology Laboratory. There are three nuclear medicine 
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specialist, two residents, a physicist and IT specialist, a biologist, 
a radiation protection adviser, NM technicians, specialized nurses, 
and supportive and administrative personnel.
The Scintigraphic Laboratory is equipped with the most 
up-to-date diagnostic equipment including, among other things, 
two-head rotary gamma cameras coupled with computed to-
mography (SPECT/CT hybrids), a Technegas generator, and 
an automatic radionuclide dosage system. The installed computer 
network enables the transferral of images using telemedicine, and 
adequate data processing systems make it possible to superim-
pose images obtained by different techniques. Approximately 
3200-3400 scintigraphic studies are performed each year. 
A list of in vivo investigations performed in the department, 
in order of descending frequency is as follows: 1. Bone scan: 
planar, dynamic study, SPECT, SPECT-CT, “bone evolution”; 2. 
Myocardial perfusion, stress, and rest test with 99mTc-MIBI, gated 
SPECT ; 3. Whole-body scan with 131I after hyperthyroid therapy 
and treatment of thyroid cancer with 131I ; 4. Thyroid scan with 99mTc 
and 131II 5. Renal scan (static and dynamic); 6. Lung perfusion 
scan (planar, SPECT); 7. Lung ventilation scan with “Technegas”; 
8. Somatostatin Receptor Scintigraphy with SPECT/CT system; 
9. Lymphoscintigraphy for sentinel node mapping with hybrid 
SPECT/CT system; 10. Parathyroid scan (dual-isotope subtraction 
technique); 11. Radioisotope cisternography; 12. Brain SPECT; 13. 
Whole body scan with Lu-117, SM-153 and Y-90; 14. Liver/Spleen 
Figure 1. The representatives of the Committee for Accreditation on 
Nuclear Medicine Department CANMD and Accredited Departments. 
Prof. Eugeniusz Dziuk is first on the right. Figure 2. UEMS/EBNM European Accreditation Diploma.
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scan ;15. Cardiac MUGA study; 16. Dacryoscintigraphy and oc-
casionally inflammation scintigraphy, and others. 
The Radioimmunological Laboratory performs in vitro mea-
surements of endocrinological and oncological analytes. In the 
laboratory the radioimmunological investigations, immunometric, 
and other immunochemical methods are applied. The following 
studies are done routinely: 
1.  Thyrological analytes: TSH, FT3, FT4, antithyroglobulin, and 
antithyroperoxidase autoantibodies, autoantibodies against 
TSH receptor; 
2.  Tumour markers: CEA, AFP, CA 19-9, CA 15-3, HCG, NSE, 
Cyfra 21-1, chromogranin A, calcitonin, thyroglobulin; 
3.  Vitamins: vit. B12, folate acid, vit. D 
4.  Other endocrinological analytes: 17 OH progesteron, andros-
tenedion, testosterone, DHEAS, PTH, HGH, IGF1, ACTH, active 
renin, aldosterone, insulin, C-peptide, procalcitonin
The results are constantly subjected to internal and external 
laboratory audits by international institutions. 
The Department of Nuclear Medicine cooperates closely with 
the Department of Endocrinology and Isotope Therapy (located in 
the same building) and carries out diagnostic scintigraphic exami-
nations, mainly in patients treated with radionuclides. Moreover, 
the Laboratory cooperates with the remaining departments of the 
Military Institute of Health Services and with the Mazovian PET-CT 
Centre located in the same area.
In 1997 the Task Group for the Accreditation of Nuclear Medi-
cine Facilities was established on behalf of the EANM (European 
Association of Nuclear Medicine) and the UEMS/EBNM (European 
Union of Medical Specialist/European Board of Nuclear Medicine) 
to implement the introduction of an accreditation system in Europe. 
The approach that has been adopted and was agreed to by both 
the EANM and UEMS/EBNM is intended to enhance the average 
quality of nuclear medicine services within Europe and is based 
on three separate items: 1. A quality system which is externally 
verified; 2. Qualified staffing; and 3. The use of accepted nuclear 
medicine protocols 
The general philosophy adopted by the Task Group for the 
Accreditation of Nuclear Medicine facilities has been to develop 
a minimum basis for accreditation, with as much flexibility as pos-
sible to take into account the lack of harmonization that exists in 
Europe at present. It is intended that accreditation will be a dynamic 
process capable of incorporating new features as these become 
available, with progressive harmonization of regulations and 
qualifications within Europe.
The development of the Quality Manual was completed at the 
end of 1998.During 1999 a pilot study to prepare a department 
for certification under ISO 9002/94 was undertaken in St. Etienne, 
France under the direction of Dr. Eric Gremillet.
In 2000 a pilot study was started and continued in 2001 with the 
aim of preparing nine European departments for certification with 
respect to ISO 9001:2000. This study focused on cardiovascular 
nuclear medicine.
The participants were: I. Carrió, Barcelona, Spain; P. Franken, 
Brussels, Belgium; R. Giubbini, Brescia, Italy; E. Gremillet, St. 
Etienne, France; O. Lang, Prague, Czech Republic; J. Mueller, 
Basle, Switzerland; O. Schober, Muenster, Germany; M. Schwaiger, 
Munich, Germany; and R. Underwood, United Kingdom.
The Task Group became a permanent UEMS/EBNM Commit-
tee under the name of CANMD — Committee for the Accreditation 
of Nuclear Medicine Departments — in 2004.
The current UEMS/EANM Committee for the Accreditation of 
Nuclear Medicine Departments includes: P. Van Boxem (Belgium) 
— Chair, A. García-Burillo (Spain), A.J. Hilson (United Kingdom), 
S. Mirzaei (Austria), N. Mutlukoca (Norway), G.C. Vivian (United 
Kingdom), E. Zerbib (France), and M. Bajc (Sweden)
Major achievements of the Committee:
— publication of a downloadable tool for ISO certification in 2006;
— creation of a list of corresponding members; 
— cooperation with IAEA in the area of self-appraisal auditing in 
nuclear medicine;
— cooperation with AIPES in the area of safety and security of 
isotope transportation;
— cooperation with STUK regarding the creation of guidelines on 
clinical auditing in the field of radiology for the European Com-
mission;
— numerous publications on important topics for nuclear medi-
cine (97/43/Euratom, Clinical Auditing, etc.) during lunch ses-
sions of the EANM congresses; 
— accredited department satisfaction survey;
— software user satisfaction survey;
— accreditation of more than 60 nuclear medicine departments. 
The introduction of accreditation of Nuclear Medicine facili-
ties could have the following benefits: 
— it would be initiated by the profession before being imposed by 
an outside body with little or no understanding of the specialty;
— it would increase the quality of nuclear medicine facili-
ties across Europe, which would have the added benefit of 
increasing public awareness and the credibility of the specialty, 
and improved patient referrals;
— accreditation could be used as part of the process of recognition 
of centres for teaching in nuclear medicine (physicians, radiop-
harmacists, physicists, technologists, etc.) by EANM and UEMS; 
— accredited departments could have an added advantage with 
reimbursement discussions with third parties and also tender-
ing for the provision of services;
— it would assist in better departmental risk management, even 
when the technical standard is already high, because of better 
quality documentation. 
Efficiency and therefore cost effectiveness should be an ad-
ditional benefit. 
European Accreditation is the basis for the Implementation of 
Council Directive 97/43 EURATOM via the ISO standards or the 
IAEA process. With the accreditation of your Nuclear Medicine 
Department you can stay in touch with the CANMD, which is also 
very active in the application of Clinical Audits as required by the 
Council Directive 97/43 EURATOM.
Detailed information can be found on the web page 
UEMS/EBNM/Committees /Accr. of NM Departments/ e-mail: 
office@uems.eanm.org
This article is based on information received from the ac-
credited department and from the UEMS/EBNM web page at : 
www.eanm.org.
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